Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Incipient Schizophrenia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Incipient Schizophrenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abi-Dargham, A; Buchsbaum, M; Goodman, M; Harvey, P; Koenigsberg, HW; Laruelle, M; Mitropoulou, V; Siever, LJ1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Incipient Schizophrenia

ArticleYear
Cognitive and brain function in schizotypal personality disorder.
    Schizophrenia research, 2002, Mar-01, Volume: 54, Issue:1-2

    Topics: Benzamides; Brain; Cognition Disorders; Contrast Media; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Pyrrolidines; Schizotypal Personality Disorder; Tomography, Emission-Computed, Single-Photon

2002